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Abstract: Best’s vitelliform macular dystrophy complicated with choroidal neovascularization 
is rare in children. We report three children from a Malay family of five siblings with Best’s 
vitelliform macular dystrophy, in which two of them subsequently developed choroidal 
 neovascularization. The possible pathogenesis of this rare condition is described and high-
lighted in this report.
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Introduction
Best’s vitelliform macular dystrophy with childhood onset causes a slowly progres-
sive central visual impairment. It is inherited in an autosomal-dominant manner in the 
majority of cases. Though choroidal neovascularization secondary to Best’s vitelliform 
macular dystrophy is rare, it is known to cause childhood blindness if left untreated.1 
We report three brothers of a Malay family with Best’s vitelliform macular dystrophy, 
two of whom developed unilateral choroidal neovascularization. Rapid diagnosis and 
prompt treatment of this condition are essential to prevent significant visual loss in 
these children.
Case report
Case 1
The eldest child was referred to our clinic for bilateral hypermetropia by a private 
optometrist at the age of 9 years. His cycloplegic refraction was +7.00/−0.50 × 170 
in the right eye and +7.75/−0.75 × 20 in the left eye. He was prescribed glasses that 
successfully corrected visual acuity to 6/6 in both eyes. Fundoscopic examination 
revealed localized elevated foveal lesions with yellowish deposit in both eyes, which 
were suggestive of Best’s vitelliform macular dystrophy. The electrooculogram was 
abnormal, with Arden ratios of 1.1 in the right eye and 1.3 in the left eye. Fam-
ily screening revealed that two of his younger brothers had similar fundoscopic 
findings.
The patient’s visual acuity remained stable until the age of 18 years, when he 
complained of a sudden painless reduction in vision in the right eye, lasting 3 weeks. 
Visual acuity had deteriorated to 6/36 in the affected eye, while his left eye’s vision 
remained at 6/7.5. Fundoscopic examination revealed evidence of Best’s vitelli-
form macular dystrophy bilaterally, with a submacular hemorrhage in the right eye 
(Figure 1A and B). Fundus fluorescein angiography of the right eye showed a net of 
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Figure 1 (Continued)
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Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy
Figure 1 (A–H) Case 1. Color fundus photograph of the right eye at presentation, showing submacular hemorrhage and a yellowish fibrotic nodule (A). Color fundus 
photograph of the left eye, showing a dome-shaped elevation at the foveal region with the presence of yellowish deposits (B). Fundoscopy of the right eye, showing 
resolved subretinal hemorrhage with residual scarring at the foveal region at 2 months posttreatment (C). Fundoscopy of the left eye, showing similar findings to those at 
presentation (D). Fundus fluorescein angiogram, showing increased hyperfluorescence at the macula, consistent with choroidal neovascularization (E early phase, F late phase). 
Optical coherence tomography of the right eye at presentation, showing a subretinal pigment epithelium fibrotic nodule with a subretinal reflection of a subfoveal choroidal 
neovascularization and surrounding subretinal fluid (G). Optical coherence tomography of the right eye at 2 months posttreatment, showing resolution of the subretinal fluid 
at the right macula (H). Green lines indicate the cross-section of the macula shown by the adjacent optical coherence tomography image.
increasing hyperfluorescence at the macula, consistent with 
a choroidal neovascularization (Figure 1E and F). Optical 
coherence tomography of his right eye revealed subretinal 
reflection of subfoveal choroidal neovascularization with 
surrounding subretinal edema (Figure 1G).
The patient was treated with a single dose of intravitreal 
1.0 mg ranibizumab under sub-Tenon’s local anesthesia. Two 
months later, his visual acuity improved to 6/12, and fundo-
scopic examination showed that the subretinal hemorrhage had 
resolved, with residual scarring at the subfoveal region in the 
affected eye (Figure 1C and D). These findings were supported 
by optical coherence tomography imaging (Figure 1H).
He was last evaluated at 9 months posttreatment. His 
best-corrected visual acuity was 6/9 in the right eye and 
6/7.5 in the left eye. Fundoscopic examination remained 
stable, with no evidence of recurrence in the right eye or 
new neovascularization in the left eye.
Case 2
The third child was first examined at 4 years. He was 
 asymptomatic. His best-corrected visual acuity was 6/6 
in both eyes. Serial fundoscopy findings revealed signs of 
Best’s vitelliform macular dystrophy. There were no signs of 
submacular hemorrhage to suggest the presence of choroidal 
neovascularization (Figure 2A and B). Optical coherence 
tomography demonstrated minimal signs of subretinal fluid 
accumulation in both eyes (Figure 2C and D).
Case 3
The fourth child was diagnosed with Best’s vitelliform 
macular dystrophy at 4 years old after a family eye screening. 
At the age of 6 years, he developed a choroidal neovascu-
larization in the right eye (Figure 3A and B), and that was 
promptly managed.2
Currently, his visual acuity is 6/6 in both eyes. 
 Fundoscopic examination (Figure 3C and D) remains stable 
in both eyes, 3 years after the intravitreal ranibizumab 
 injection in the right eye. No systemic or ocular complica-
tions were observed throughout his follow-up.
Detailed clinical presentations of the aforementioned 
patients and their unaffected siblings are summarized in 
Table 1. There is no history of consanguinity. Fundoscopic 
examinations of the second and youngest siblings showed 
normal findings. Electrooculography was performed in the 
two older brothers, but was not performed in other siblings, 
because they were too young at the time of examination. 
Examination of the parents’ eyes was essentially normal, 
except for the fact that their mother had a hyperpigmented flat 
scar in her left macula. Genetic analysis was not performed 
due to financial constraints.
Discussion
Familial cases of Best’s vitelliform macular dystrophy have 
been described amongst the Spanish, Danish, Italian, French, 
American, and Chinese.3–7 Based on a PubMed literature 
search, the present study is the first report of familial Best’s 
vitelliform macular dystrophy in individuals of Malay decent, 
and two of the described children had presented with active 
choroidal neovascularization.
Zhang et al performed a postmortem examination and 
described the histopathological findings in two eyes with 
clinical diagnosis of Best’s vitelliform macular dystrophy. 
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Figure 2 (A–D) Case 2. Color fundus photograph of the right (A) and left (B) eyes showing dome-shaped elevation of the foveal regions, with the presence of yellowish 
deposits, signifying Best’s vitelliform macular dystrophy. Optical coherence tomography of the right (C) and left (D) eye revealed the presence of subretinal fluid at the foveal 
regions. Green lines indicate the cross-section of the macula shown by the adjacent optical coherence tomography image.
They reported a well-circumscribed area of retinal pigment 
epithelium (RPE) hyperplasia, accumulation of lipofuscin 
in the RPE, deposition of granular material in the photore-
ceptors, macrophages, and drusen. They also observed an 
area in the region of a large sub-RPE drusen where Bruch’s 
membrane was not intact.8
Interestingly, in an animal study, Julien et al found that 
zinc deficiency in the pigmented eyes of rats yielded an 
increased lipofuscin accumulation in the RPE, with decreased 
melanosomes in its microvilli and irregular thickness of 
Bruch’s membrane.9 This condition may facilitate the pen-
etration of macrophages from the choroid to the RPE.
RPE dysfunction in Best’s vitelliform macular dystrophy 
causes the accumulation of subretinal fluid, which elevates 
the retinal layers away from the RPE, making the phagocy-
tosis of the photoreceptor outer segment less likely to occur. 
The eventual phagocytosis of older photoreceptor outer 
segment loads the RPE with precursor for lipofuscin. The 
increased oxidative stress that leads to lipofuscinogenesis 
increases the amount of free radicals, which further damage 
the retinal architecture. This postulation probably explains 
the initiation of choroidal neovascularization formation in 
Best’s vitelliform macular dystrophy.
Querques et al reported that bestrophin mutation did not 
correlate with disease severity.10 Both the age of onset and 
disease progression were highly variable in patients with 
the same mutation. Therefore, the variability shown by these 
three Malay brothers regarding age of onset and disease pro-
gression could not be explained. It is difficult to deduce why 
choroidal neovascularization had developed in these two 
siblings but not in the other brother, who also showed clinical 
signs of Best’s vitelliform macular dystrophy.  Interestingly, 
we observed that the two siblings who had developed 
choroidal neovascularization demonstrated larger areas of 
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Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy
Figure 3 (A–D) Case 3. Color fundus photographs of the fourth child at the time of diagnosis of choroidal neovascularization (A and B). right fundoscopy at 3 years 
posttreatment, showing a resolved subfoveal hemorrhage with a residual dome-shaped elevation and yellowish deposits at the foveal region (C). Left fundoscopy at 3 years 
postpresentation, showing an increase in the size of the dome-shaped elevation, with no sign of a submacular hemorrhage (D).
Table 1 Clinical summary
Siblings During presentation Complicated by CNV Current status
Age, 
years
Sex BCVA Fundoscopy Arden 
ratio
Affected 
eye
Age, 
years
BCVA Treatment Age, 
years
BCVA
eldest 9 Male re: 6/6  
Le: 6/6
Bilateral Best’s 
vitelliform macular 
dystrophy
re: 1.1  
Le: 1.3
right eye 18 re: 6/36 
Le: 6/7.5
single-dose  
intravitreal  
ranibizumab 1.0 mg
19 re: 6/9 
Le: 6/7.5
second 6 Male re: 6/6  
Le: 6/6
Normal re: 1.2  
Le: 1.2
No Nil Nil Nil 16 re: 6/6 
Le: 6/6
Third 4 Male re: 6/9  
Le: 6/9
Bilateral Best’s 
vitelliform macular 
dystrophy
Na No Nil Nil Conservative  
treatment
14 re: 6/6 
Le: 6/6
Fourth 4 Male re: 6/9  
Le: 6/9
Bilateral Best’s 
vitelliform macular 
dystrophy
Na right eye 6 re: 6/18 
Le: 6/6
single-dose  
intravitreal  
ranibizumab 1.0 mg
10 re: 6/6 
Le: 6/6
Youngest 1 Male 20/100 
binocular
Normal Na No Nil Nil Nil 7 re: 6/6 
Le: 6/6
Abbreviations: re, right eye; Le, left eye; CNV, choroidal neovascularization; BCVa, best-corrected visual acuity; Na, not available.
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subretinal fluid accumulation and deposits compared to the 
sibling without choroidal neovascularization formation. We 
postulate that the severity of RPE dysfunction and an increase 
in oxidative stress play important roles in the formation of 
choroidal neovascularization.
Both of the patients responded well to the single dose 
of intravitreal ranibizumab. The eldest child showed stable 
visual acuity and fundoscopy findings 9 months after treat-
ment, while the fourth child has not had any recurrence 
3 years later. No recurrence or adverse events were noted 
throughout their follow-up visits. This observation is con-
sistent with an observation by Ruiz-Moreno et al,11 where 
they described an excellent outcome in a 3-year follow-up of 
a boy who was treated with a single injection of intravitreal 
ranibizumab for choroidal neovascularization secondary to 
Best’s vitelliform macular dystrophy.
Conclusion
Choroidal neovascularization secondary to Best’s vitel-
liform macular dystrophy is uncommon in the pediatric 
community. Two siblings with choroidal neovascularization 
is particularly unusual. Prompt diagnosis and management of 
this condition are vital to prevent blindness in these children. 
A single dose of intravitreal ranibizumab was effective in 
our patients, but this treatment requires long-term follow-up 
and monitoring.
Disclosure
The authors report no conflicts of interest in this work.
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